Trident Lifeline Limited Increases Shareholding in Subsidiary Trident Mediquip Limited to 59.77%

Trident Lifeline Limited has announced the acquisition of an additional 2.67% equity stake in its subsidiary Trident Mediquip Limited, increasing its shareholding from 57.10% to 59.77%. The company disclosed this information to BSE Limited on March 18, 2026, under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Acquisition Details

The acquisition involved purchasing additional equity shares from existing shareholders of Trident Mediquip Limited. Prior to this transaction, Trident Lifeline's shareholding in the subsidiary had decreased to 57.10% following a private placement of equity shares to other shareholders by Trident Mediquip Limited.

Parameter:	Details
Pre-acquisition Holding:	57.10%
Additional Stake Acquired:	2.67%
Post-acquisition Holding:	59.77%
Transaction Type:	Acquisition from existing shareholders

About Trident Mediquip Limited

Trident Mediquip Limited is a subsidiary company incorporated under the provisions of the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals industry and was incorporated on October 19, 2019.

Financial Parameter:	Details
Authorized Share Capital:	Rs. 10,00,00,000
Paid-up Share Capital:	Rs. 9,81,58,000
Number of Equity Shares:	98,15,800 shares of Rs. 10 each
Current Turnover:	21.29 Cr
CIN:	U33309GJ2019PLC110421

Historical Performance

The subsidiary's turnover performance over the last three financial years shows:

Financial Year:	Turnover
2022-23:	28.77 Cr
2023-24:	20.58 Cr
2024-25:	21.29 Cr

Related Party Transaction

The acquisition qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. Several promoters and promoter group members, including directors and their relatives, have interests in both entities. The company has confirmed that the transaction is being undertaken on an arm's length basis.

Regulatory Compliance

The disclosure was made in compliance with SEBI (LODR) Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company secretary and compliance officer Nikita Sharma signed the regulatory filing on March 18, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.03%	+7.42%	-2.04%	-11.43%	-1.31%	+143.64%

Hardik Desai Family Trust has submitted a regulatory disclosure to BSE Limited regarding its recent acquisition of shares in Trident Lifeline Limited . The disclosure, filed in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, details the trust's increased shareholding in the company.

The trust, operating through its Ultimate Beneficial Owner (UBO) Hardik Jigishkumar Desai, is categorized as a promoter group entity. Desai is based in Surat, Gujarat, and serves as the trustee of the family trust.

Share Acquisition Details

The transaction involved the acquisition of 4,200 equity shares through open market purchases on 12.03.2026. This acquisition represents a modest increase in the trust's shareholding position.

Parameter:	Before Acquisition	After Acquisition	Change
Number of Shares:	8,38,766	8,42,966	+4,200
Percentage of Total Share Capital:	7.03%	7.06%	+0.03%
Percentage of Diluted Capital:	6.72%	6.75%	+0.03%

Company Capital Structure

Trident Lifeline Limited's equity share capital remained unchanged following the transaction. The company maintains an equity share capital structure as detailed below:

Capital Type:	Amount	Number of Shares
Equity Share Capital:	Rs. 11,93,30,000	1,19,33,000 shares of Rs. 10 each
Total Diluted Capital:	Rs. 12,49,34,000	1,24,93,400 shares of Rs. 10 each

The diluted share capital accounts for the potential conversion of outstanding convertible securities and warrants into equity shares.

Regulatory Compliance

The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The trust confirmed that it holds no encumbered shares, voting rights other than through shares, or convertible instruments that would entitle it to additional voting rights in the company.

The transaction represents a routine open market acquisition by a promoter group entity, maintaining transparency in shareholding changes as required by regulatory frameworks. Trident Lifeline Limited's shares are listed on BSE Limited under scrip code 543616.